Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Effect of genetic variations on adjusting of warfarin dose].

Tuberkuloz ve toraks - 1 Jan 2014

Darılmaz Yüce Gülbahar

Abstract excerpt

Warfarin is the most widely used oral anticoagulant. Since it has a limited therapeutics index, anticoagulant reaction is mostly needed to be controlled in patients taking warfarin. Besides age, gender, medicines taken with comorbidities, the variations in pharmacokinetics and pharmacogenetic genes also affect the dose of warfarin. VKORC1 and CYP2C9 are two genes responsible for warfarin metabolism. Today the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Blood Coagulation
Share to Cytochrome P-450 CYP2C9

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to VKORC1 gene

Share to Genetic Variation

Share to Polymorphism, Genetic

Share to Vitamin K Epoxide Reductases

Share to Warfarin

Source

Identifiers

PMID: 25492821

Genes

VKORC1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Effect of genetic variations on adjusting of warfarin dose].PMID 25492821Read ↗

[Warfarin resistance and related pharmacogenetic information].Semantic proximity Read ↗

The impact of genetic polymorphisms and patient characteristics on warfarin dose requirements: a cross-sectional study in Iran.Semantic proximity Read ↗

Effect of CYP2C9 and VKORC1 genetic variations on warfarin dose requirements in Indian patients.Semantic proximity Read ↗

Integrated analysis of clinical and genetic factors on the interindividual variation of warfarin anticoagulation efficacy in clinical practice.Semantic proximity Read ↗

Factors affecting warfarin dose requirements and quality of anticoagulation in adult Egyptian patients: role of gene polymorphism.Semantic proximity Read ↗

Investigating warfarin variability : the contribution of clinical, genetic, and environmental factorsSemantic proximity Read ↗

[Association between CYP2C9 and VKORC1 genetic polymorphism and warfarin dose requirements].Semantic proximity Read ↗

[Oral anticoagulation and pharmacogenetics: importance in the clinical setting].Semantic proximity Read ↗

Oral anticoagulants: Pharmacogenetics Relationship between genetic and non-genetic factors.Semantic proximity Read ↗

VKORC1 and CYP2C9 genotype distribution in Asian countries.Semantic proximity Read ↗

A regulatory science perspective on warfarin therapy: a pharmacogenetic opportunity.Semantic proximity Read ↗

[Genetic and bioenvironmental factors associated with warfarin response in Colombian patients].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.